Elekta AB (publ) (OTCMKTS:EKTAY) Sets New 52-Week Low – Here’s Why

Elekta AB (publ) (OTCMKTS:EKTAY)’s stock price hit a new 52-week low on Wednesday . The stock traded as low as $5.78 and last traded at $5.81, with a volume of 2020 shares traded. The stock had previously closed at $5.98.

Elekta AB (publ) Stock Down 2.8 %

The company has a current ratio of 0.99, a quick ratio of 0.74 and a debt-to-equity ratio of 0.45. The business’s 50-day simple moving average is $6.52 and its 200-day simple moving average is $6.66. The company has a market capitalization of $2.23 billion, a PE ratio of 20.73 and a beta of 1.23.

Elekta AB (publ) (OTCMKTS:EKTAY) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $359.76 million for the quarter. Elekta AB (publ) had a net margin of 6.25% and a return on equity of 12.23%. As a group, equities research analysts anticipate that Elekta AB will post 0.41 EPS for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, September 27th. Shareholders of record on Monday, September 9th were paid a dividend of $0.114 per share. The ex-dividend date of this dividend was Monday, September 9th. Elekta AB (publ)’s payout ratio is currently 39.29%.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.